Pharmaceutical Information |
Drug Name |
Guanabenz acetate |
Drug ID |
BADD_D01044 |
Description |
An alpha-2 selective adrenergic agonist used as an antihypertensive agent. [PubChem] |
Indications and Usage |
For management of High blood pressure |
Marketing Status |
Prescription; Discontinued |
ATC Code |
Not Available |
DrugBank ID |
DB00629
|
KEGG ID |
D00605
|
MeSH ID |
D006143
|
PubChem ID |
5702062
|
TTD Drug ID |
D0L4HY
|
NDC Product Code |
86036-002 |
Synonyms |
Guanabenz | 2,6-Dichlorobenzylideneaminoguanidine | 2,6 Dichlorobenzylideneaminoguanidine | Guanabenz Acetate | Acetate, Guanabenz | Guanabenz Monoacetate | Monoacetate, Guanabenz | Wytensin | Wyeth-Ayerst of Guanabenz Acetate | Acetate Wyeth-Ayerst, Guanabenz | Guanabenz Acetate Wyeth-Ayerst | Wyeth Ayerst of Guanabenz Acetate | BR-750 | BR 750 | BR750 | WY-8678 | WY 8678 | WY8678 |
|
Chemical Information |
Molecular Formula |
C10H12Cl2N4O2 |
CAS Registry Number |
23256-50-0 |
SMILES |
CC(=O)O.C1=CC(=C(C(=C1)Cl)C=NN=C(N)N)Cl |
Chemical Structure |
|
|
ADR Related Proteins Induced by Drug |
ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
Not Available | Not Available | Not Available | Not Available | Not Available |
|
ADRs Induced by Drug |
|